© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 12, 950-951,
June 19, 2002
© 2002 Oxford University Press
CORRESPONDENCE |
RESPONSE: Re: Effects of N-(4-Hydroxy-phenyl)retinamide on hTERT Expression in the Bronchial Epithelium of Cigarette Smokers
Affiliations of authors: J.-C. Soria, Division of Cancer Medicine, Institut Gustave Roussy, Villejuif, France; C. Moon, Department of Oncology and Head and Neck Cancer Research Institute, Johns Hopkins University School of Medicine, Baltimore, MD; L. Mao, Molecular Biology Laboratory, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston.
Correspondence to: Li Mao, M.D., Molecular Biology Laboratory, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Box 432, 1515 Holcombe Blvd., Houston, TX 77030 (e-mail: lmao@mdanderson.org).
Bowman et al. confirmed our earlier observation that the human telomerase reverse transcriptase calatylic subunit (hTERT) is expressed in microscopically normal bronchial epithelia by analyzing hTERT mRNA expression in pathological samples from 28 patients who underwent definitive surgical resection for stage IIII non-small-cell lung cancer. In our study, hTERT mRNA was detectable, by
REFERENCES